Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Share News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
566.00    0.00 (0.00%)
Bid:
564.50
Ask:
573.00
Spread: 8.50 (1.506%)
Market Cap: £2.50b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Tate & Lyle unveils restructuring plans

Tue, 21st Apr 2015 08:42
Food ingredients maker Tate & Lyle is set to implement a restructuring process, which will see the company leave the majority of its European bulk ingredients business and make changes to its Splenda sucralose division.The FTSE 250 group said it will receive €240m (£172.58m) from Archer Daniels Midland, after agreeing to exit bulk ingredients plants in Bulgaria, Turkey and Hungary that are operated by both groups as part of a European corn wet-milling joint venture.As part of the deal, which is expected to be completed in the summer and which will bring the proportion of profits Tate earns from specialty ingredients up 5% to 55%, the London-listed company will also take full ownership of a more specialty-focused plant in Slovakia.In a statement released on Tuesday, Tate added that in a bid to reduce productions costs, it will close a Singapore facility in the spring of 2016 and consolidate production of all its Splenda sucralose at a facility in Alabama.Following the move, the company, which forecast one-time net charges of approximately £125m, said it expected the business to achieve breakeven in the year to March 2016 and to return to "modest profitability" in the year ending March 2017.The group added it would recommend an unchanged final dividend for the year ended March 2015 that would make the total for the year 28 pence per share, up 1.4% year-on-year.Tate & Lyle shares were up 0.69% to 658.00p at 08:59 on Tuesday.

Related News

LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP
9 Jun 2026

LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent
9 Jun 2026

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Be...

Tate & Lyle News

LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP
9 Jun 2026

LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent
9 Jun 2026

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Be...

UK's FTSE 100 recovers from lows as Israel and Iran halt strikes on each other
8 Jun 2026

UK's FTSE 100 recovers from lows as Israel and Iran halt strikes on each other

June 8 (Reuters) - UK's FTSE 100 ended flat on Monday, well off its ​session ‌lows as oil prices eased a touch after Iran and Israel said they would s...

LONDON MARKET CLOSE: Stocks mixed amid lack of Middle East progress
8 Jun 2026

LONDON MARKET CLOSE: Stocks mixed amid lack of Middle East progress

(Alliance News) - The FTSE 100 edged higher on Monday on a mixed day for stocks in London, as US markets recouped some of Friday's hefty falls and inv...

LONDON MARKET MIDDAY: FTSE 100 recovers despite intensifying Iran war
8 Jun 2026

LONDON MARKET MIDDAY: FTSE 100 recovers despite intensifying Iran war

(Alliance News) - Stock prices in London were mixed at midday on Monday, as the FTSE 100 recovered from earlier losses, with investors rattled by rene...

WINNERS & LOSERS: Housebuilders, airlines fall on Middle East flare-up
8 Jun 2026

WINNERS & LOSERS: Housebuilders, airlines fall on Middle East flare-up

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday.

Ingredion to buy UK's Tate & Lyle for $3.6 billion
8 Jun 2026

Ingredion to buy UK's Tate & Lyle for $3.6 billion

* Deal values Tate & Lyle at £3.8 billion including ​debt